ENTITY

Aethlon Medical (AEMD US)

20
Analysis
Health Care • United States
Aethlon Medical, Inc. operates as a medical device company. The Company provides a platform to develop medical devices that target the selective removal of disease-promoting particles from the circulatory system. Aethlon Medical develops medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.
more
bullish•Aethlon Medical
•15 Nov 2025 05:00•Issuer-paid

Aethlon Medical Inc - Currently

Currently, Hemopurifier treatment requires a dialysis machine and nephrologists and dialysis nurses to supervise and administer the...

Share
bullish•Aethlon Medical
•22 Oct 2025 23:00•Issuer-paid

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...

Share
bullish•Aethlon Medical
•21 Oct 2025 22:00•Issuer-paid

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...

Share
bullish•Aethlon Medical
•11 Oct 2025 07:00•Issuer-paid

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...

Share
bullish•Aethlon Medical
•11 Oct 2025 02:00•Issuer-paid

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended

Levels of certain harmful particles typically returned to pre-treatment levels 1-3 weeks after treatment ended, suggesting a potential benefit to...

Share
x